moxalactam has been researched along with Peritoneal Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geheber, CE; Kolb, L; Stone, HH | 1 |
| Dunlop, WE; Fabian, TC; Stone, HH; Strom, PR | 1 |
| Arensman, JB; Harris, RW; Moore, WL; Rissing, JP | 1 |
2 trial(s) available for moxalactam and Peritoneal Diseases
| Article | Year |
|---|---|
Moxalactam versus gentamicin-clindamycin in surgical sepsis. Efficacy and safety.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Child; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Moxalactam; Peritoneal Diseases; Postoperative Complications; Prospective Studies; Random Allocation | 1983 |
Third-generation cephalosporins for polymicrobial surgical sepsis.
Topics: Abscess; Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Child; Clindamycin; Clinical Trials as Topic; Female; Gentamicins; Humans; Kidney Diseases; Male; Middle Aged; Moxalactam; Peritoneal Diseases; Peritonitis; Postoperative Complications; Random Allocation; Surgical Wound Infection | 1983 |
1 other study(ies) available for moxalactam and Peritoneal Diseases
| Article | Year |
|---|---|
Antimicrobial activity of latamoxef (moxalactam) against both Bacteroides fragilis and Escherichia coli in an intraperitoneal abscess model.
Topics: Abscess; Animals; Ascitic Fluid; Bacteroides fragilis; Bacteroides Infections; Escherichia coli Infections; Moxalactam; Peritoneal Diseases; Rabbits | 1984 |